{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:02:50Z","timestamp":1783576970069,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T00:00:00Z","timestamp":1433808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan","award":["(C) KAKENHI 15K08464"],"award-info":[{"award-number":["(C) KAKENHI 15K08464"]}]},{"name":"Research Grant for Neuroimmunological Diseases from the Ministry of Health, Labour and Welfare of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00415-015-7806-4","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T02:13:32Z","timestamp":1433729612000},"page":"1954-1960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barr\u00e9 syndrome and its variants"],"prefix":"10.1007","volume":"262","author":[{"given":"Michiaki","family":"Koga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,9]]},"reference":[{"key":"7806_CR1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.clinph.2012.01.025","volume":"123","author":"A Uncini","year":"2012","unstructured":"Uncini A, Kuwabara S (2012) Electrodiagnostic criteria for Guillain-Barr\u00e8 syndrome: a critical revision and the need for an update. Clin Neurophysiol 123:1487\u20131495","journal-title":"Clin Neurophysiol"},{"key":"7806_CR2","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP (2012) Guillain-Barr\u00e9 syndrome. N Engl J Med 366:2294\u20132304","journal-title":"N Engl J Med"},{"key":"7806_CR3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","volume":"48","author":"K Ogawara","year":"2000","unstructured":"Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N (2000) Axonal Guillain-Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:624\u2013631","journal-title":"Ann Neurol"},{"key":"7806_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(03)00013-3","volume":"210","author":"K Ogawara","year":"2003","unstructured":"Ogawara K, Kuwabara S, Koga M, Mori M, Yuki N, Hattori T (2003) Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection. J Neurol Sci 210:41\u201345","journal-title":"J Neurol Sci"},{"key":"7806_CR5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Mech\u00e9 FG, Herbrink P, Schmitz PI, de Klerk MA et al (1998) The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case\u2013control study. Neurology 51:1110\u20131115","journal-title":"Neurology"},{"key":"7806_CR6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cen3.12007","volume":"4","author":"K Kaida","year":"2013","unstructured":"Kaida K (2013) Pathogenic roles of antiganglioside antibodies in immune-mediated neuropathies. Clin Exp Neuroimmunol 4:60\u201369","journal-title":"Clin Exp Neuroimmunol"},{"key":"7806_CR7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jns.2007.09.020","volume":"266","author":"E Nobile-Orazio","year":"2008","unstructured":"Nobile-Orazio E, Gallia F, Terenghi F, Allaria S, Giannotta C, Carpo M (2008) How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? J Neurol Sci 266:156\u2013163","journal-title":"J Neurol Sci"},{"key":"7806_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-5728(96)00059-8","volume":"68","author":"S Irie","year":"1996","unstructured":"Irie S, Saito T, Nakamura K, Kanazawa N, Ogino M, Nukazawa T et al (1996) Association of anti-GM2 antibodies in Guillain-Barr\u00e9 syndrome with acute cytomegalovirus infection. J Neuroimmunol 68:19\u201326","journal-title":"J Neuroimmunol"},{"key":"7806_CR9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jnnp.62.6.641","volume":"62","author":"BC Jacobs","year":"1997","unstructured":"Jacobs BC, van Doorn PA, Groeneveld JH, Tio-Gillen AP, van der Mech\u00e9 FG (1997) Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry 62:641\u2013643","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7806_CR10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-510X(97)00174-3","volume":"154","author":"N Yuki","year":"1998","unstructured":"Yuki N, Tagawa Y (1998) Acute cytomegalovirus infection and IgM anti-GM2 antibody. J Neurol Sci 154:14\u201317","journal-title":"J Neurol Sci"},{"key":"7806_CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/mus.880180407","volume":"18","author":"S Kusunoki","year":"1995","unstructured":"Kusunoki S, Chiba A, Hitoshi S, Takizawa H, Kanazawa I (1995) Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection. Muscle Nerve 18:409\u2013413","journal-title":"Muscle Nerve"},{"key":"7806_CR12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-5728(02)00209-6","volume":"130","author":"CW Ang","year":"2002","unstructured":"Ang CW, Tio-Gillen AP, Groen J, Herbrink P, Jacobs BC, Van Koningsveld R (2002) Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barr\u00e9 syndrome. J Neuroimmunol 130:179\u2013183","journal-title":"J Neuroimmunol"},{"key":"7806_CR13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.54.7.1453","volume":"54","author":"CW Ang","year":"2000","unstructured":"Ang CW, Jacobs BC, Brandenburg AH, Laman JD, van der Mech\u00e9 FG (2000) Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barr\u00e9 syndrome. Neurology 54:1453\u20131458","journal-title":"Neurology"},{"key":"7806_CR14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.57.4.736","volume":"57","author":"S Kusunoki","year":"2001","unstructured":"Kusunoki S, Shiina M, Kanazawa I (2001) Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry. Neurology 57:736\u2013738","journal-title":"Neurology"},{"key":"7806_CR15","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27 (suppl)","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol 27 (suppl):S21\u2013S24","journal-title":"Ann Neurol"},{"key":"7806_CR16","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s00415-011-6360-y","volume":"259","author":"M Koga","year":"2012","unstructured":"Koga M, Gilbert M, Takahashi M, Li J, Hirata K, Kanda T et al (2012) GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J Neurol 259:1366\u20131374","journal-title":"J Neurol"},{"key":"7806_CR17","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp-2012-303060","volume":"83","author":"M Koga","year":"2012","unstructured":"Koga M, Kusunoki S, Kaida K, Uehara R, Nakamura Y, Kohriyama T et al (2012) Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics. J Neurol Neurosurg Psychiatry 83:1210\u20131215","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7806_CR18","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/01.WNL.0000160399.08456.7C","volume":"64","author":"M Koga","year":"2005","unstructured":"Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furukawa K et al (2005) Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64:1605\u20131611","journal-title":"Neurology"},{"key":"7806_CR19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/JCM.43.1.335-339.2005","volume":"43","author":"M Takahashi","year":"2005","unstructured":"Takahashi M, Koga M, Yokoyama K, Yuki N (2005) Epidemiology of Campylobacter jejuni-isolated Guillain-Barr\u00e9 and Fisher syndromes in Japan. J Clin Microbiol 43:335\u2013339","journal-title":"J Clin Microbiol"},{"key":"7806_CR20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/499969","volume":"193","author":"M Koga","year":"2006","unstructured":"Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K et al (2006) Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis. J Infect Dis 193:547\u2013555","journal-title":"J Infect Dis"},{"key":"7806_CR21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1212\/WNL.47.3.668","volume":"47","author":"LH Visser","year":"1996","unstructured":"Visser LH, van der Mech\u00e9 FG, Meulstee J, Rothbarth PP, Jacobs BC, Schmitz PI et al (1996) Cytomegalovirus infection and Guillain-Barr\u00e9 syndrome: the clinical, electrophysiologic, and prognostic features. Neurology 47:668\u2013673","journal-title":"Neurology"},{"key":"7806_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","volume":"40","author":"BC Jacobs","year":"1996","unstructured":"Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH et al (1996) Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barr\u00e9 syndrome. Ann Neurol 40:181\u2013187","journal-title":"Ann Neurol"},{"key":"7806_CR23","first-page":"297","volume":"25","author":"S Kuwabara","year":"2002","unstructured":"Kuwabara S, Nakata M, Sung JY, Mori M, Kato N, Hattori T et al (2002) Hyperreflexia in axonal Guillain-Barr\u00e9 syndrome subsequent to Campylobacter jejuni enteritis. J Neurol Sci 25:297\u2013299","journal-title":"J Neurol Sci"},{"key":"7806_CR24","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000244468.22377.6b","volume":"67","author":"K Kimoto","year":"2006","unstructured":"Kimoto K, Koga M, Odaka M, Hirata K, Takahashi M, Li J et al (2006) Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology 67:1837\u20131843","journal-title":"Neurology"},{"key":"7806_CR25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0006-3002(57)90254-8","volume":"24","author":"L Svennerholm","year":"1957","unstructured":"Svennerholm L (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 24:604\u2013611","journal-title":"Biochim Biophys Acta"},{"key":"7806_CR26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0000000000000566","volume":"83","author":"S Sawai","year":"2014","unstructured":"Sawai S, Satoh M, Mori M, Misawa S, Sogawa K, Kazami T et al (2014) Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barr\u00e9 syndrome. Neurology 83:113\u2013117","journal-title":"Neurology"},{"key":"7806_CR27","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1212\/WNL.0000000000001090","volume":"83","author":"K Miyaji","year":"2014","unstructured":"Miyaji K, Devaux J, Yuki N (2014) Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barr\u00e9 syndrome. Neurology 83:2314","journal-title":"Neurology"},{"key":"7806_CR28","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/S0021-9258(18)68935-5","volume":"263","author":"AA Ilyas","year":"1988","unstructured":"Ilyas AA, Li SC, Chou DK, Li YT, Jungalwala FB, Dalakas MC, Quarles RH (1988) Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. J Biol Chem 263:4369\u20134373","journal-title":"J Biol Chem"},{"key":"7806_CR29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/01.WNL.0000081229.88862.C6","volume":"61","author":"K Kaida","year":"2003","unstructured":"Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I (2003) GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody. Neurology 61:465\u2013470","journal-title":"Neurology"},{"key":"7806_CR30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2005.07.063","volume":"1057","author":"H Yoshino","year":"2005","unstructured":"Yoshino H, Utsunomiya I, Taguchi K, Ariga T, Nagaoka T, Aoyagi H (2005) GalNAc-GD1a is localized specifically in ventral spinal roots, but not in dorsal spinal roots. Brain Res 1057:177\u2013180","journal-title":"Brain Res"},{"key":"7806_CR31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0165-5728(00)00451-3","volume":"113","author":"K Kaida","year":"2001","unstructured":"Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I (2001) Guillain-Barr\u00e9 syndrome with IgM antibody to the ganglioside GalNAc-GD1a. J Neuroimmunol 113:260\u2013267","journal-title":"J Neuroimmunol"},{"key":"7806_CR32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410350510","volume":"35","author":"S Kusunoki","year":"1994","unstructured":"Kusunoki S, Chiba A, Kon K, Ando S, Arisawa K, Tate A (1994) N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barr\u00e9 syndrome. Ann Neurol 35:570\u2013576","journal-title":"Ann Neurol"},{"key":"7806_CR33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/123.1.116","volume":"123","author":"K Kaida","year":"2000","unstructured":"Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I (2000) Guillain-Barr\u00e9 syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 123:116\u2013124","journal-title":"Brain"},{"key":"7806_CR34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<702::AID-MUS6>3.0.CO;2-A","volume":"23","author":"R Kaji","year":"2000","unstructured":"Kaji R, Kusunoki S, Mizutani K, Oka N, Kojima Y, Kohara N et al\u00a0(2000) Chronic motor axonal neuropathy associated with antibodies monospecific for N-acetylgalactosaminyl GD1a. Muscle Nerve 23:702\u2013706","journal-title":"Muscle Nerve"},{"key":"7806_CR35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jns.2004.07.011","volume":"225","author":"K Taguchi","year":"2004","unstructured":"Taguchi K, Ren J, Utsunomiya I, Aoyagi H, Fujita N, Ariga T (2004) Neurophysiological and immunohistochemical studies on Guillain-Barr\u00e9 syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission. J Neurol Sci 225:91\u201398","journal-title":"J Neurol Sci"},{"key":"7806_CR36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1085-9489.2005.0010209.x","volume":"10","author":"K Kamakura","year":"2005","unstructured":"Kamakura K, Kaida K, Kusunoki S, Miyamoto N, Masaki T, Nakamura R (2005) Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia. J Peripher Nerv Syst 10:190\u2013201","journal-title":"J Peripher Nerv Syst"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7806-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7806-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7806-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T20:08:10Z","timestamp":1652299690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7806-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,9]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["7806"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7806-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,9]]}}}